In the context of the challenges affecting all economies, Romania is in a good position from several points of view. The beginning of the new legislative and governmental mandates following the election from December 2020 is expected to ensure political and economic stability in the next four years, 2021 opens a new period of granting EU funds, GDP is forecasted to grow by 3.7% in 2021 and 3.9% in 2022-, and the economy would reach the pre-crisis level of output earlier than anticipated.
Potential in the Romanian medtech and healthcare market
The pandemic experience calls for a reform of the Romanian medical infrastructure, as well as a reform in terms of its ownership, financing, operation, and maintenance. The available options include public private partnerships and community based cooperative organizations. A high degree of overlapping interests of the government and private medical sector creates preconditions for successful public-private partnerships (PPP). Keeping up with the rapid development of medicine requires continuous investment in medical technology and expertise.
The Romanian MedTech market is constantly growing and has great potential. Swiss companies active in the MedTech industry can expect high returns whenever their products are selected and distributed in Romania.
Report: attractive opportunities for Swiss companies
The report, which can be downloaded below, is provided by the Chamber of Commerce Switzerland – Romania. Download it now to get an overview of the healthcare system and medical technology market, learn about the medical infrastructure and how the funding and investments work. In the report you can also find a listing of the most important projects from 2021 – 2027, a description of how procurement practices work and relevant contacts. Everything a Swiss medtech company looking to expand to Romania needs in terms of initial information.